Načítá se...
Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis
The main protease (M(pro)) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an important therapeutic target as it plays a major role in the processing and maturation of the viral polyprotein. GC376 is a pre-clinical dipeptide-based protease inhibitor that has been previously used f...
Uloženo v:
| Vydáno v: | Ann Med Surg (Lond) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7797473/ https://ncbi.nlm.nih.gov/pubmed/33456770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amsu.2020.12.030 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|